These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19900316)

  • 21. Artesunate, artemether or quinine in severe Plasmodium falciparum malaria?
    Checkley AM; Whitty CJ
    Expert Rev Anti Infect Ther; 2007 Apr; 5(2):199-204. PubMed ID: 17402835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Widespread availability of artemisinin monotherapy in the United States.
    Rakita RM; Malhotra U
    Emerg Infect Dis; 2011 May; 17(5):954-5. PubMed ID: 21529430
    [No Abstract]   [Full Text] [Related]  

  • 23. Artemether-lumefantrine and liver enzyme abnormalities in non-severe Plasmodium falciparum malaria in returned travellers: a retrospective comparative study with quinine-doxycycline in a Portuguese centre.
    Silva-Pinto A; Ruas R; Almeida F; Duro R; Silva A; Abreu C; Sarmento A
    Malar J; 2017 Jan; 16(1):43. PubMed ID: 28122572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apparent drug failure following artesunate treatment of Plasmodium falciparum malaria in Freetown, Sierra Leone: four case reports.
    Sahr F; Willoughby VR; Gbakima AA; Bockarie MJ
    Ann Trop Med Parasitol; 2001 Jul; 95(5):445-9. PubMed ID: 11487367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Availability of parenteral quinine.
    McHugh GJ
    Anaesth Intensive Care; 2001 Dec; 29(6):670. PubMed ID: 11771618
    [No Abstract]   [Full Text] [Related]  

  • 26. Cost-effectiveness analysis of artesunate and quinine + tetracycline for the treatment of uncomplicated falciparum malaria in Chanthaburi, Thailand.
    Honrado ER; Fungladda W; Kamoiratanaku P; Kitayaporn D; Karbwang J; Thimasarn K; Masngammueng R
    Bull World Health Organ; 1999; 77(3):235-43. PubMed ID: 10212514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malaria: severe, life threatening.
    Omari A; Garner P
    Clin Evid; 2004 Jun; (11):1047-57. PubMed ID: 15652052
    [No Abstract]   [Full Text] [Related]  

  • 28. No Reduction in Hemoglobin Level in Severe Plasmodium falciparum Malaria Treated with Artesunate in Central Sudan.
    Eltahir HG; Bilal JA; Ali EA; Adam I
    J Trop Pediatr; 2017 Feb; 63(1):18-22. PubMed ID: 27370816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic evaluation of artesunate and three quinine regimens in the treatment of severe malaria in children at the Ebolowa Regional Hospital-Cameroon: a cost analysis.
    Maka DE; Chiabi A; Obadeyi B; Mah E; Nguefack S; Nana P; Mbacham W; Mbonda E
    Malar J; 2016 Dec; 15(1):587. PubMed ID: 27923381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The treatment of severe malaria.
    Dondorp AM; Day NP
    Trans R Soc Trop Med Hyg; 2007 Jul; 101(7):633-4. PubMed ID: 17434195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shifting from quinine to artesunate as first-line treatment of severe malaria in children and adults: saving more lives.
    Noubiap JJ
    J Infect Public Health; 2014; 7(5):407-12. PubMed ID: 24894306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parenteral antimalarial drugs: availability in acute hospitals.
    Panday S; Raynor DK
    BMJ; 1989 Dec; 299(6713):1436. PubMed ID: 2514828
    [No Abstract]   [Full Text] [Related]  

  • 33. Severe unresolving
    Al-Zaydani IA; Al-Hakami A; Kumar A; Abdalla SA; Otaif M; Thiqa R; Ahmed H; Alnahili K
    Indian J Med Microbiol; 2016; 34(4):553-557. PubMed ID: 27934844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Quinine. Treatment of malaria].
    Gerson C
    Soins; 1996; (602-603):69-70. PubMed ID: 8715766
    [No Abstract]   [Full Text] [Related]  

  • 35. Making antimalarial agents available in Africa.
    Arrow KJ; Gelband H; Jamison DT
    N Engl J Med; 2005 Jul; 353(4):333-5. PubMed ID: 16000348
    [No Abstract]   [Full Text] [Related]  

  • 36. [Parenteral combined quinine-artesunate therapy in life-threatening malaria].
    Richter J; Abbasi-Boroudjeni N; Koch S; Müller-Stöver I; Häussinger D
    Dtsch Med Wochenschr; 2009 Jan; 134(5):187-90. PubMed ID: 19180405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combating malaria. Malaria treatment: ACT two.
    Enserink M
    Science; 2007 Oct; 318(5850):560-3. PubMed ID: 17962536
    [No Abstract]   [Full Text] [Related]  

  • 38. Quinine, Malaria, and the Cinchona Bureau: Marketing Practices and Knowledge Circulation in a Dutch Transoceanic Cinchona-Quinine Enterprise (1920s-30s).
    Van Der Hoogte AR; Pieters T
    J Hist Med Allied Sci; 2016 Apr; 71(2):197-225. PubMed ID: 26054829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The in-vitro susceptibilities of Ghanaian Plasmodium falciparum to antimalarial drugs.
    Quashie NB; Duah NO; Abuaku B; Koram KA
    Ann Trop Med Parasitol; 2007 Jul; 101(5):391-8. PubMed ID: 17550644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An operational comparative study of quinine and artesunate for the treatment of severe malaria in hospitals and health centres in the Democratic Republic of Congo: the MATIAS study.
    Ferrari G; Ntuku HM; Burri C; Tshefu AK; Duparc S; Hugo P; Mitembo DK; Ross A; Ngwala PL; Luwawu JN; Musafiri PN; Ngoie SE; Lengeler C
    Malar J; 2015 May; 14():226. PubMed ID: 26024661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.